Alzamend Neuro Inc (ALZN) has fallen Tuesday morning, with the stock losing -20.86% in pre-market trading to 1.1. ALZN's short-term technical score of 0 indicates that the stock has traded less bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 0% of stocks. Alzamend Neuro Inc has fallen 53.97% over the past month, closing at $2.91 on October 24. During this period of time, the stock fell as low as $1.36 and as high as $3.12. ALZN has an average analyst recommendation of Strong Buy. The company has an average price target of $14.99.
ALZN has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on ALZN!